Chemokine receptor antagonists and methods of use therefor
CA 2319077 A1 · Owner: Kyowa Hakko Kogyo Co. Ltd. · Inventors: Nakasato, Yoshisuke; Ohshima, Etsuo; Luly, Jay R.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation. The method comprises administering to a subject in need an effective amount of a compound represented by structural formula (I) and physiologically acceptable salts thereof.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 21, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 21, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 21, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.